CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 28 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 25.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $33,000 | -23.3% | 86,456 | -0.0% | 0.00% | – |
| Q4 2015 | $43,000 | -2.3% | 86,477 | +0.0% | 0.00% | – |
| Q3 2015 | $44,000 | -36.2% | 86,435 | +0.0% | 0.00% | – |
| Q2 2015 | $69,000 | -10.4% | 86,393 | +0.0% | 0.00% | – |
| Q1 2015 | $77,000 | +28.3% | 86,372 | +0.1% | 0.00% | – |
| Q4 2014 | $60,000 | -77.1% | 86,309 | +0.1% | 0.00% | – |
| Q3 2014 | $262,000 | +20.2% | 86,246 | +21.0% | 0.00% | – |
| Q2 2014 | $218,000 | -16.8% | 71,273 | -0.0% | 0.00% | – |
| Q1 2014 | $262,000 | -8.4% | 71,294 | +0.1% | 0.00% | – |
| Q4 2013 | $286,000 | -5.9% | 71,231 | +0.1% | 0.00% | – |
| Q3 2013 | $304,000 | +44.8% | 71,189 | +0.1% | 0.00% | – |
| Q2 2013 | $210,000 | – | 71,147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,356,091 | $1,202,000 | 0.05% |
| VANGUARD GROUP INC | 6,177,466 | $156,921,000 | 0.01% |
| SHUFRO ROSE & CO LLC | 17,500 | $8,000 | 0.00% |
| LEAVELL INVESTMENT MANAGEMENT, INC. | 12,000 | $6,000 | 0.00% |
| PACIFIC GLOBAL INVESTMENT MANAGEMENT CO | 10,000 | $5,000 | 0.00% |
| Glassman Wealth Services | 2,197 | $1,000 | 0.00% |
| Krilogy Financial LLC | 600 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5,856 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 33,166 | $17,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 86,435 | $44,000 | 0.00% |